PlainRecalls
FDA Drug Moderate Class II Completed

Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90

Reported: November 2, 2022 Initiated: October 5, 2022 #D-0021-2023

Product Description

Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90

Reason for Recall

CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

Details

Recalling Firm
Aurobindo Pharma USA Inc.
Units Affected
9504 bottles
Distribution
Nationwide
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90. Recalled by Aurobindo Pharma USA Inc.. Units affected: 9504 bottles.
Why was this product recalled?
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 2, 2022. Severity: Moderate. Recall number: D-0021-2023.